Vigeo Therapeutics

Vigeo Therapeutics

Biotechnology, 545 Concord Ave, Cambridge, , 2138, Massachusetts, United States, 1-10 Employees

vigeotherapeutics.com

  • twitter
  • LinkedIn

Who is VIGEO THERAPEUTICS

Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.

Read More

map
  • 545 Concord Ave, Cambridge, Massachusetts, 2138, United States Headquarters: 545 Concord Ave, Cambridge, Massachusetts, 2138, United States
  • 2011 Date Founded: 2011
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VIGEO THERAPEUTICS

Vigeo Therapeutics Org Chart and Mapping

Employees

Jing Watnick

CEO, President, Board Director

Judy Chiao

Senior Vice President Clinical Development

Harold Pestana

Head of Clinical Operations

Aurelia Mickunas

Senior R&D Project Manager

Suming Wang

Associate Director, Translational Sciences

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vigeo Therapeutics

Answer: Vigeo Therapeutics's headquarters are located at 545 Concord Ave, Cambridge, , 2138, Massachusetts, United States

Answer: Vigeo Therapeutics's official website is https://vigeotherapeutics.com

Answer: Vigeo Therapeutics's revenue is $1 Million to $5 Million

Answer: Vigeo Therapeutics's SIC: 2834

Answer: Vigeo Therapeutics's NAICS: 325412

Answer: Vigeo Therapeutics has 1-10 employees

Answer: Vigeo Therapeutics is in Biotechnology

Answer: Vigeo Therapeutics contact info: Phone number: Website: https://vigeotherapeutics.com

Answer: Vigeo Therapeutics is a clinical stage company developing novel therapeutic agents for the treatment of cancer.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access